A drug therapy for epilepsy and shingles pain is being voluntarily recalled by its manufacturer due to complaints of empty capsules. The empty capsules of gabapentin could result in a reduction in efficacy, short-term withdrawal, or long-period seizures, which could be life-threatening, according to an FDA MedWatch alert.
Aurobindo Pharma USA announced it would recall lot GESB14011-A of gabapentin capsules, USP 300 mg 100-count bottles because of the error. The bottles have an expiration date of December 2015 and were distributed through the Northstar label to retail outlets across the nation.
